Skip to main content
Clinical Trials/NCT05097469
NCT05097469UnknownNot Applicable

Randomized, Double-blind, Sham-controlled Clinical Trial for Evaluating the Efficacy of Fractional Carbon Dioxide Laser in the Treatment of Female Sexual Dysfunction.

Rambam Health Care Campus1 site in 1 country120 target enrollmentStarted: October 4, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
120
Locations
1
Primary Endpoint
Vaginal health index

Study Overview

Brief Summary

The study is intended to assess the safety and efficacy of Carbon dioxide AcuPulse laser treatment in patients with sexual dysfunction. Eligible subjects will be randomized to either receive 3 laser or 3 sham treatment sessions, 4 weeks apart and 3 follow up visits 3, 6 and 12 months following the last treatment.

Detailed Description

Following a screening visit, eligible subjects will be enrolled into the study. Subjects will be randomized into either laser treatment or sham treatment. Each subject will receive 3 treatments 4 weeks apart and 3 follow up visits, at 3, 6 and 12 months following the last treatment.

Further demographic information and patient history will be obtained from the subjects' electronic files.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Care Provider)

Eligibility Criteria

Ages
30 Years to 70 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Negative urine analysis.
  • •Normal Pap smear test from the recent 3 years.
  • •No previous gynecological laser treatments.
  • •Able and willing to comply with the treatment/follow-up schedule and requirements.

Exclusion Criteria

  • •Active genital infection.
  • •Subject presenting abnormal Pap result from the last three years.
  • •Recurring urinary tract infection or recurring infection of genital herpes or candida (> 2 episodes in the recent year).
  • •Transvaginal mesh implant.
  • •Serious systemic disease or any chronic condition that could interfere with study compliance.
  • •Any vaginal bleeding of unknown reason.

Arms & Interventions

Laser treatment

Active Comparator

Carbon dioxide laser treatment

Intervention: Carbon dioxide laser (Device)

Sham treatment

Sham Comparator

Sham laser treatment

Intervention: Sham laser treatment (Device)

Outcomes

Primary Outcomes

Vaginal health index

Time Frame: From treatment up to 12 months post treatment

Change in total and specific vaginal health index scores

Secondary Outcomes

  • Sexual intercourse(From treatment up to 12 months post treatment)
  • Female sexual function index(From treatment up to 12 months post treatment)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

ROY LAUTERBACH MD

Principal investigator

Rambam Health Care Campus

Study Sites (1)

Loading locations...

Similar Trials